[Skip to Navigation]
July 9, 2020

Time to Focus on Value-Based Metrics for Cancer Care?

Author Affiliations
  • 1Seidman Cancer Center, Breast Center Operations–University Hospitals, Case Western Reserve School of Medicine, Cleveland, Ohio
  • 2University Hospitals of Cleveland, Case Western Reserve School of Medicine, Cleveland, Ohio
  • 3Professor Francis Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, Ohio
JAMA Oncol. 2020;6(9):1325-1326. doi:10.1001/jamaoncol.2020.0792

Despite dramatic advances in medicine, health care still causes harm too often, costs too much, and improves too slowly. This has led many payers and policy makers to focus on improving value, which includes quality, patient experience, and cost of care. Despite national attention on providing value in medicine, measures of value have been slow to emerge. We believe that professional societies have an opportunity to collaborate and develop standards that include not only outcomes but also patient experience and cost.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words